Prophylactic Antibiotic in Treatment of Fingertip Amputation

Fingertip amputation is a common injury. Considerable controversy exists as to whether prophylactic antibiotics are necessary for this injury. The investigators goal was to compare the rate of infections among subgroups with and without prophylactic antibiotic treatment. The study hypothesis was that infection rates were similar in the two groups.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Infection Rate After Fingertip Amputation

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

HaEmek medical center

Afula, 18101, Israel

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

fingertip amputation with bone exposed

Exclusion criteria

under the age of 18 years
if the patient had diabetes
oncological disorder
immune deficiency
bleeding disorder
used steroids regularly
presented with a grossly contaminated wound or other injury requiring antibiotic treatment
were currently taking antibiotics, or had a previous allergic reaction to cephalosporins.

Treatment and study plan

Cephazolin

Drug

Cephazolin

Other names: Cefamezine

Primary outcomes

infection rate

Time frame: 1 month

Sponsors and collaborators

Lead sponsor

HaEmek Medical Center, Israel

Other

Registry information

Official study title

The Use of Prophylactic Antibiotic in Treatment of Fingertip Amputation: A Randomized Prospective Trial

Important dates

Study start: 2006
Primary completion: 2015
Study completion: 2015
First posted: Mar 4, 2014
Registry last updated: Jul 10, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.